ReviewDrugs2018

Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology.

Susanne Juhl Pedersen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.